Paxlovid components, molecular models

---

Paxlovid components, molecular models. The image shows the two components of paxlovid, PF-07321332 (bottom) and ritonavir (top). PF-07321332 is a new antiviral drug acting as a protease inhibitor in the treatment of COVID-19. Ritonavir slows down the metabolism of PF-07321332. As of 2021, paxlovid is in phase III trials.

---

Size: 4150px × 4150px
Location:
Photo credit: © LAGUNA DESIGN/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, 2019-, artwork, background, biology, black, corona, coronavirus, covid-19, disease, illustration, inhibitor, main, medical, medicine, microbiological, microbiology, particle, pathogen, paxlovid, pf-07321332, pfizer, protease, ritonavir, rna, sars-cov2, viral, virion, virology, virus